ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025
Erratum: Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.